Context Therapeutics grants new hire stock options for 146,000 shares at $0.7 each

Context Therapeutics granted a new employee non-qualified stock options for 146,000 shares as an inducement award. The grant date is July 7, 2026, with an exercise price of $0.7 per share. The options have a 10-year term and vest over four years, with 25% vesting after one year and the remainder monthly over 36 months.

Context Therapeutics granted a non-qualified stock option for 146,000 shares to a new employee, issued as an inducement award. * Grant date was July 7, 2026; exercise price set at $0.7 per share, matching the Nasdaq close. * Options carry a 10-year term; vest over four years with 25% after one year, then monthly over 36 months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Context Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607101605PRIMZONEFULLFEED9760394) on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)